Notice: This company has been marked as potentially delisted and may not be actively trading. Soaring Eagle Acquisition (SRNG) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends SRNG vs. KRYS, ADMA, ACLX, CRSP, IMVT, IBRX, DNLI, VCEL, KYMR, and SWTXShould you be buying Soaring Eagle Acquisition stock or one of its competitors? The main competitors of Soaring Eagle Acquisition include Krystal Biotech (KRYS), ADMA Biologics (ADMA), Arcellx (ACLX), CRISPR Therapeutics (CRSP), Immunovant (IMVT), ImmunityBio (IBRX), Denali Therapeutics (DNLI), Vericel (VCEL), Kymera Therapeutics (KYMR), and SpringWorks Therapeutics (SWTX). Soaring Eagle Acquisition vs. Krystal Biotech ADMA Biologics Arcellx CRISPR Therapeutics Immunovant ImmunityBio Denali Therapeutics Vericel Kymera Therapeutics SpringWorks Therapeutics Krystal Biotech (NASDAQ:KRYS) and Soaring Eagle Acquisition (NASDAQ:SRNG) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations. Is KRYS or SRNG more profitable? Krystal Biotech has a net margin of 21.68% compared to Soaring Eagle Acquisition's net margin of 0.00%. Krystal Biotech's return on equity of 7.54% beat Soaring Eagle Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets Krystal Biotech21.68% 7.54% 6.97% Soaring Eagle Acquisition N/A N/A N/A Does the MarketBeat Community prefer KRYS or SRNG? Krystal Biotech received 286 more outperform votes than Soaring Eagle Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformKrystal BiotechOutperform Votes28667.14% Underperform Votes14032.86% Soaring Eagle AcquisitionN/AN/A Which has preferable earnings & valuation, KRYS or SRNG? Krystal Biotech has higher revenue and earnings than Soaring Eagle Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKrystal Biotech$50.70M102.84$10.93M$1.77102.42Soaring Eagle AcquisitionN/AN/AN/AN/AN/A Does the media favor KRYS or SRNG? In the previous week, Krystal Biotech had 4 more articles in the media than Soaring Eagle Acquisition. MarketBeat recorded 5 mentions for Krystal Biotech and 1 mentions for Soaring Eagle Acquisition. Krystal Biotech's average media sentiment score of 1.43 beat Soaring Eagle Acquisition's score of 0.20 indicating that Krystal Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Krystal Biotech 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Soaring Eagle Acquisition 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend KRYS or SRNG? Krystal Biotech presently has a consensus price target of $202.29, suggesting a potential upside of 11.58%. Given Krystal Biotech's stronger consensus rating and higher possible upside, research analysts clearly believe Krystal Biotech is more favorable than Soaring Eagle Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Krystal Biotech 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00Soaring Eagle Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals believe in KRYS or SRNG? 86.3% of Krystal Biotech shares are held by institutional investors. Comparatively, 41.2% of Soaring Eagle Acquisition shares are held by institutional investors. 14.1% of Krystal Biotech shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryKrystal Biotech beats Soaring Eagle Acquisition on 13 of the 13 factors compared between the two stocks. Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Get Soaring Eagle Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRNG vs. The Competition Export to ExcelMetricSoaring Eagle AcquisitionBiological Products, Except Diagnostic IndustryEnergy SectorNASDAQ ExchangeMarket Cap$1.37B$2.98B$8.58B$8.84BDividend YieldN/A1.91%11.47%4.07%P/E RatioN/A19.4015.8914.22Price / SalesN/A286.46128.7188.42Price / CashN/A169.3811.4736.27Price / BookN/A4.483.366.37Net IncomeN/A-$41.63M$952.17M$225.56M Soaring Eagle Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRNGSoaring Eagle AcquisitionN/A$6.36-1.4%N/A+324.3%$1.37BN/A0.00N/ANews CoverageKRYSKrystal Biotech4.7675 of 5 stars$181.29+1.8%$202.29+11.6%+70.0%$5.21B$50.70M100.62229Positive NewsADMAADMA Biologics3.3244 of 5 stars$21.360.0%$21.25-0.5%+430.3%$5.05B$258.21M76.32530ACLXArcellx2.9367 of 5 stars$87.96+0.8%$103.08+17.2%+65.8%$4.76B$110.32M-124.80130Short Interest ↓CRSPCRISPR Therapeutics1.7975 of 5 stars$46.36-1.9%$74.94+61.6%-34.5%$3.96B$371.21M-16.31473IMVTImmunovant1.5501 of 5 stars$26.62+1.7%$48.10+80.7%-22.6%$3.91BN/A0.00120IBRXImmunityBio0.7381 of 5 stars$5.08+4.1%$4.75-6.5%+20.4%$3.54B$620,000.000.00590Positive NewsDNLIDenali Therapeutics4.4921 of 5 stars$24.49+0.3%$38.90+58.8%+27.3%$3.52B$330.53M0.00364VCELVericel1.1053 of 5 stars$57.86+1.0%$58.14+0.5%+56.1%$2.86B$197.52M954.49300Analyst ForecastKYMRKymera Therapeutics1.4142 of 5 stars$44.040.0%$52.13+18.4%+110.9%$2.85B$78.59M0.00170Analyst ForecastSWTXSpringWorks Therapeutics2.0604 of 5 stars$36.31-3.0%$67.00+84.5%+68.5%$2.70B$5.45M0.00305Analyst Forecast Related Companies and Tools Related Companies KRYS Alternatives ADMA Alternatives ACLX Alternatives CRSP Alternatives IMVT Alternatives IBRX Alternatives DNLI Alternatives VCEL Alternatives KYMR Alternatives SWTX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SRNG) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soaring Eagle Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soaring Eagle Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
